Express News | Zhejiang Orient Gene Biotech: Wholly-owned and holding subsidiaries have obtained medical instruments registration certificates.

BreakingsJan 22 16:19

Oriental Biotech: 2024 Annual Results Pre-loss Announcement

SZSIJan 17 00:00 · Announcements

2024 Annual Results Advance Loss Announcement

SZSIJan 17 00:00 · Announcements

January 17 A-shares investment warning highlights︱ *ST Baoxin: Received a preliminary notice of the proposed termination of the company’s Stocks listing; LONGi Green Energy Technology: Expected loss of 8.2 billion yuan to 8.8 billion yuan for the year 202

Zhejiang Orient Gene Biotech: Expected loss of 0.485 billion yuan to 0.535 billion yuan for the year 2024.

Gelonghui FinanceJan 16 21:57

Express News | Zhejiang Orient Gene Biotech: Expected annual Net income loss of 0.485 billion yuan to 0.535 billion yuan for 2024.

BreakingsJan 16 17:26

Chinese Stocks Plunge as Manufacturing Slowdown Dampens Sentiment; Huafu Fashion Down 4%

MT NewswiresJan 2 15:45